OVA Peptide 257-264 2TFA 1262751-08-5(TFA-2TFA)
CAS No. ——
OVA Peptide 257-264 2TFA 1262751-08-5(TFA-2TFA)( —— )
Catalog No. M22904 CAS No. ——
OVA Peptide 257-264 2TFA is a class I (Kb)-restricted peptide epitope of OVA, an octameric peptide from ovalbumin presented by the class I MHC molecule, H-2Kb.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 400 | In Stock |
|
| 10MG | 668 | In Stock |
|
| 25MG | 1019 | In Stock |
|
| 50MG | 1560 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOVA Peptide 257-264 2TFA 1262751-08-5(TFA-2TFA)
-
NoteResearch use only, not for human use.
-
Brief DescriptionOVA Peptide 257-264 2TFA is a class I (Kb)-restricted peptide epitope of OVA, an octameric peptide from ovalbumin presented by the class I MHC molecule, H-2Kb.
-
DescriptionOVA Peptide 257-264 2TFA is a class I (Kb)-restricted peptide epitope of OVA, an octameric peptide from ovalbumin presented by the class I MHC molecule, H-2Kb.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight1191.17
-
Molecular FormulaC49H76F6N10O17
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC[C@H](N)C(N[C@H](C(N[C@H](C(N[C@@H](CC(N)=O)C(N[C@H](C(N[C@@H](CCC(O)=O)C(N[C@@H](CCCCN)C(N[C@@H](CC(C)C)C(O)=O)=O)=O)=O)CC1=CC=CC=C1)=O)=O)[C@@H](C)CC)=O)[C@@H](C)CC)=O.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wick MJ, et al. Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation. Eur J Immunol. 1996 Nov;26(11):2790-9.
molnova catalog
related products
-
Atrial Natriuretic P...
Auriculin B (ANP (126-150) (Rat)) is a rat-derived atrial natriuretic peptide. Auriculin B has potent vasodilatory and diuretic properties.
-
4-Hydroxyisophthalic...
Used as pharmaceutical intermediates.
-
BDA 366
BDA-366 specifically targets the BH4 domain of Bcl2 BDA-366 and suppresses human myeloma growth. BDA-366 induces robust apoptosis in MM cell lines and primary MM cells by inducing BCL2 conformational change.
Cart
sales@molnova.com